Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 3-DIMENSIONAL PHARMACEUTICALS (DDDP) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (28)	10/2/2001 10:47:25 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 146

Bio.com's InFocus series on "Drug Discovery" begins with an examination of advances in the field of Chemical Genomics. This feature includes a live panel discussion web cast in STREAMING AUDIO. To join us for this discussion on Thursday, October 4th at 10am Pacific Time (1pm EDT), go to: bio.com (Be sure to copy the entire URL and paste it into your browser.) Leaders in the field of Chemical Genomics will discuss how to integrate genomic tools with diversity-oriented chemistry in order to design better drugs more rapidly and efficiently. Panelists: Dirk Vetter, Ph.D. CEO and Co-Founder Graffinity Matthew D. Shair, Ph.D. Professor of Chemistry and Chemical Biology Harvard University Mark R. Player, M.D., Ph.D. Director of Chemistry 3-Dimensional Pharmaceuticals * For complete instructions on how to tune in to Bio.com's streaming discussions, go to: bio.com To submit questions for our panelists, go here: bio.com For upcoming InFocus features: bio.com